1.
Open Forum Infect Dis
; 4(2): ofx065, 2017.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28584851
RESUMO
This retrospective study reports the data of sofosbuvir-based anti-hepatitis C virus treatment in 24 candidates and 24 recipients of liver transplantation coinfected with human immunodeficiency virus. Sustained virologic response was cumulatively 85% (90% and 100% in those treated with optimal schedules pre- and posttransplant, respectively).